January 1st. Dr. Ole Henrik Brekke joined Nextera as the Chief Business Officer. Ole Henrik has a strong track record in developing companies from the idea stage into successful clinical stage. In addition, he has a profound scientific background in phage display, protein engineering and immunology being manifested in high impact journals like Nature and PNAS.
“The combination of Ole Henrik’s solid scientific fundament with his ability to leverage biotech companies are exactly what Nextera was looking for and we are very pleased that Ole Henrik wanted to join us as a team member.” CEO, Geir Åge Løset says in a comment.
“I’m really looking forward to contribute to Nextera’s development with its unique NextCore platform. I certainly believe that Nextera will be a changemaker in the immunotherapeutic drug development scene. With its hand-picked highly skilled team Nextera should make a difference in collaboration with the pharma industry”, Ole Henrik replies.